Aura Biosciences, Inc. (AURA)

Aura Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Cash & Equivalents	67.84	84.79	59.52	47.55	107.37	38.23	31.69	25.41	30.08	26.28	41.06	55.58	47.73	38.49	121.58	61.11	53.85	108.38	149.06	81.83
Short-Term Investments	256	29.94	84.73	114.31	69.94	89.77	119.4	148.97	157.34	176.6	185.09	93.47	114.28	135.03	67.23	50.41	68.28	24.9	-	-
Cash & Short-Term Investments	323.84	114.73	144.24	161.87	177.31	127.99	151.09	174.38	187.42	202.87	226.15	149.06	162.01	173.52	188.81	111.52	122.13	133.28	149.06	81.83
Cash Growth (YoY)	82.64%	-10.36%	-4.54%	-7.17%	-5.39%	-36.91%	-33.19%	16.99%	15.68%	16.91%	19.78%	33.66%	32.66%	30.19%	26.66%	36.28%	32.47%	33.72%	757.03%	-
Other Receivables	1.76	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	1.76	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	0.65	1.16	1.67	2.15	0.65	1.17	1.7	0.35	0.7	1.26	1.82	0.32	0.86	1.52	2.17	0.42	1.08	1.92	2.73	0.08
Restricted Cash	-	-	-	-	-	-	-	-	-	-	0.02	0.02	0.02	0.02	0.02	0.18	0.03	0.02	0.02	0.02
Other Current Assets	2.77	2.61	3.83	6.1	6	5.35	7.83	8.75	7.48	8.12	3.81	4.49	3.31	4.06	5.7	3.79	4.43	4.36	1.88	1.53
Total Current Assets	329.03	118.5	149.74	170.12	183.96	134.52	160.62	183.48	195.6	212.25	231.79	153.89	166.21	179.12	196.7	115.91	127.67	139.58	153.7	83.46
Property, Plant & Equipment	17.19	17.89	18.45	18.86	19.49	20.12	20.59	21.07	21.48	21.56	22	24.43	25.06	25.51	26.04	26.47	6.46	6.72	6.2	5.54
Long-Term Deferred Charges	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.58
Other Long-Term Assets	1.91	1.29	1.24	1.05	0.95	0.77	1.29	0.79	1.21	1.22	1.28	1.45	1.47	1.39	1.19	0.77	0.89	0.13	0.13	0.13
Total Assets	348.13	137.68	169.43	190.02	204.4	155.4	182.5	205.34	218.28	235.03	255.08	179.77	192.74	206.02	223.94	143.15	135.02	146.42	160.03	90.7

Liabilities

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Accounts Payable	2.25	2.57	1.55	1.89	1.29	2.01	2.3	1.99	1.46	1.93	1.79	1.49	0.55	1.06	2.92	1.72	1.2	1.96	2.4	1.74
Accrued Expenses	13.11	10.49	13.35	13.56	10.14	6.57	9.27	8.54	5.57	4.31	6.95	5.35	4.57	3.6	4.25	4.84	3.48	2.18	3.83	2.75
Current Portion of Leases	3.29	3.27	3.24	3.22	3.2	3.17	3.15	3.13	2.75	2.74	2.69	3.04	3.01	2.99	2.96	2.94	0.63	0.62	0.62	0.61
Other Current Liabilities	0.91	0.38	0.24	0.15	0.23	0.41	0.19	1.06	0.77	0.68	0.94	1.02	0.77	0.47	0.33	0.46	0.5	0.24	0.51	0.74
Total Current Liabilities	19.56	16.71	18.38	18.82	14.85	12.16	14.91	14.71	10.55	9.66	12.36	10.89	8.9	8.11	10.46	9.96	5.81	5	7.36	5.83
Long-Term Leases	13.3	13.72	14.13	14.53	14.92	15.27	15.62	15.96	16.28	16.58	16.87	17.15	17.41	17.65	17.9	18.13	0.05	0.21	0.36	0.51
Other Long-Term Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.07	0.13	-	0.07
Total Liabilities	32.86	30.43	32.52	33.36	29.77	27.44	30.53	30.67	26.83	26.24	29.23	28.05	26.3	25.76	28.35	28.09	5.93	5.34	7.72	6.42

Shareholders' Equity

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Common Stock	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Additional Paid-In Capital	914.77	621.56	617.43	611.46	603.33	529.57	525.93	522.45	518.99	515.78	512.62	417.03	413.33	408.67	406.56	309.54	307.66	306.06	304.45	9.49
Retained Earnings	-559.74	-514.1	-480.42	-454.86	-428.73	-401.71	-374.23	-348.39	-327.35	-307.01	-287.31	-265.18	-246.67	-228.37	-210.9	-194.34	-178.44	-164.97	-152.14	-140.5
Treasury Stock	-39.09	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive Income & Other	-0.67	-0.21	-0.1	0.07	0.03	0.11	0.26	0.61	-0.18	0.02	0.54	-0.13	-0.22	-0.05	-0.07	-0.15	-0.13	-0.01	-	-
Total Common Equity	315.27	107.25	136.91	156.67	174.63	127.97	151.97	174.67	191.45	208.78	225.85	151.72	166.44	180.26	195.58	115.05	129.09	141.09	152.32	-131.02
Shareholders' Equity	315.27	107.25	136.91	156.67	174.63	127.97	151.97	174.67	191.45	208.78	225.85	151.72	166.44	180.26	195.58	115.05	129.09	141.09	152.32	84.29
Total Liabilities & Equity	348.13	137.68	169.43	190.02	204.4	155.4	182.5	205.34	218.28	235.03	255.08	179.77	192.74	206.02	223.94	143.15	135.02	146.42	160.03	90.7

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Total Debt	16.59	16.99	17.38	17.75	18.11	18.44	18.77	19.08	19.03	19.32	19.56	20.19	20.42	20.64	20.86	21.07	0.68	0.83	0.98	1.12
Net Cash (Debt)	307.25	97.74	126.86	144.11	159.2	109.55	132.33	155.29	168.38	183.55	206.59	128.87	141.6	152.88	167.95	90.45	121.45	132.45	148.09	80.71
Net Cash Growth (YoY)	93.00%	-10.78%	-4.13%	-7.20%	-5.45%	-40.32%	-35.95%	20.51%	18.92%	20.06%	23.01%	42.48%	16.59%	15.43%	13.41%	12.07%	33.55%	34.04%	751.42%	-
Net Cash Per Share	3.24	1.45	1.89	2.19	2.74	2.19	2.65	3.13	3.40	3.71	4.63	3.37	3.74	4.05	5.25	3.09	4.15	4.53	7.65	182.83
Filing Date Shares Outstanding	103.7	103.39	64.15	63.5	62.12	50.27	50.23	49.95	49.61	49.54	49.5	38.26	38.2	37.8	37.8	29.33	29.27	29.26	29.22	29.21
Total Common Shares Outstanding	103.48	64.15	63.59	62.99	62.07	50.23	50	49.78	49.58	49.5	49.35	38.22	38.09	37.8	37.77	29.28	29.27	29.22	29.21	0.44
Working Capital	309.47	101.8	131.36	151.3	169.11	122.35	145.71	168.77	185.05	202.59	219.44	142.99	157.32	171.01	186.25	105.94	121.86	134.58	146.35	77.63
Book Value Per Share	3.05	1.67	2.15	2.49	2.81	2.55	3.04	3.51	3.86	4.22	4.58	3.97	4.37	4.77	5.18	3.93	4.41	4.83	5.21	-295.93
Tangible Book Value	315.27	107.25	136.91	156.67	174.63	127.97	151.97	174.67	191.45	208.78	225.85	151.72	166.44	180.26	195.58	115.05	129.09	141.09	152.32	-131.02
Tangible Book Value Per Share	3.05	1.67	2.15	2.49	2.81	2.55	3.04	3.51	3.86	4.22	4.58	3.97	4.37	4.77	5.18	3.93	4.41	4.83	5.21	-295.93
Machinery	9.01	9.02	8.98	8.86	8.81	8.67	8.46	8.3	8.03	7.84	7.8	8.21	7.92	7.6	7.43	7.04	6.9	6.04	5.64	5.22
Construction In Progress	0.29	0.31	0.23	0.14	0.15	0.25	0.27	0.52	0.95	0.56	0.39	1.45	1.6	1.76	1.81	1.98	2.18	2.85	2.37	1.74
Leasehold Improvements	0.47	0.47	0.47	0.47	0.47	0.47	0.47	0.47	-	-	-	-	-	-	-	-	0.01	0.01	0.01	0.01

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 12, 2026

Data Sources Report a data error